Paper Details

  1. Home
  2. Paper Details

Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.

Author: HreskoAndrew, LinTzu-Chieh, SolomonDaniel H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Rheumatoid arthritis (RA) is a serious and costly condition with no cure. Treatment options have expanded in recent years, including the use of biologic disease-modifying antirheumatic drugs (bDMARDs). This review examines the medical costs associated with different RA treatments, as there hasn't been a comprehensive review since the introduction of these new medications.
Paper Details　
Original Abstract of the Article :
Rheumatoid arthritis (RA) is a morbid, mortal, and costly condition without a cure. Treatments for RA have expanded over the last 2 decades, and direct medical costs may differ by types of treatments. There has not been a systematic literature review since the introduction of new RA treatments, incl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/29316377

データ提供：米国国立医学図書館（NLM）

The Cost of Rheumatoid Arthritis: A Detailed Examination

Rheumatoid arthritis (RA), like a desert wind, can be a relentless force, impacting not only physical health but also financial well-being. This study, like a meticulous archaeologist uncovering ancient ruins, meticulously examines the medical costs associated with RA in the United States. It delves into the complexities of treatment costs, particularly in the context of newer medications, including biologic disease-modifying antirheumatic drugs (bDMARDs).

Medical Costs: A Complex Landscape

The study paints a detailed picture of the financial landscape of RA treatment, revealing the significant costs associated with managing this chronic condition. This information, like a map guiding us through a desert, helps us understand the economic burden of RA and the need for effective cost-management strategies. It also emphasizes the importance of considering the long-term costs of treatment when making medical decisions.

Navigating the Costs of RA: A Call for Responsible Care

This study, like a beacon in the desert, shines a light on the need for responsible and cost-effective treatment approaches for RA. By understanding the financial realities of RA, patients, healthcare providers, and policymakers can work together to ensure that treatment remains accessible and affordable. This calls for a collaborative effort, akin to a camel caravan sharing resources, to navigate the challenging landscape of RA care.

Dr.Camel's Conclusion

This research, like a desert oasis offering respite from the harsh realities of RA, reminds us of the importance of considering both medical and economic aspects of this condition. By understanding the costs of RA treatment, we can work toward ensuring that patients receive the best possible care without facing insurmountable financial burdens. This is akin to finding a hidden spring in the desert, a source of hope and relief for those navigating the challenges of RA.

Date :
  1. Date Completed 2019-07-12
  2. Date Revised 2019-10-08
Further Info :

Pubmed ID

29316377

DOI: Digital Object Identifier

NIHMS933317

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.